Liabooks Home|PRISM News
PRISM

#Aurora Therapeutics

Total 2 articles

Visual representation of CRISPR base editing on DNA
TechEN
Aurora Therapeutics CRISPR Rare Disease Strategy Leverages New FDA Pathway

Aurora Therapeutics, cofounded by Jennifer Doudna, is using a new FDA pathway to scale personalized CRISPR treatments for rare diseases like PKU. Discover the future of bespoke medicine.

Advanced lab view with genetic code editing on digital screens
TechEN
CRISPR Personalized Gene Therapy 2026: Aurora's Umbrella Strategy

Exploring CRISPR personalized gene therapy 2026 through Aurora Therapeutics' modular approach. Learn how the 'umbrella' strategy could treat 1,600 PKU mutations.